No 340B Savings for Transgender Care Act

Hozzl · 2025-04-01T11:21:35Z

Explore the details of House Bill 2197 No 340B Savings for Transgender Care Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/1/2025, 11:21 AM

Summary of Bill HR 2197

Bill 119 HR 2197, also known as the "Preventing Misuse of 340B Program Savings Act," aims to restrict 340B covered entities from using their savings for certain medical procedures, specifically sex reassignment surgeries and hormonal therapies. The 340B program allows certain healthcare providers, such as hospitals and clinics that serve low-income populations, to purchase prescription drugs at discounted prices.

The bill seeks to prevent these entities from using their savings from the 340B program to fund sex reassignment surgeries and hormonal therapies, as well as other purposes that may not align with the original intent of the program. Supporters of the bill argue that the 340B program should be used to provide essential medications and services to underserved communities, rather than funding elective procedures.

Opponents of the bill argue that it unfairly targets transgender individuals and restricts their access to necessary medical care. They argue that healthcare decisions should be made between a patient and their healthcare provider, without government interference. Overall, Bill 119 HR 2197 raises important questions about the use of savings from the 340B program and the role of government in regulating healthcare services. It will be important to monitor the progress of this bill and consider the potential impact on both healthcare providers and patients.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 2197

Bill HR 2197 is currently in the status of Bill Introduced since March 18, 2025. Bill HR 2197 was introduced during Congress 119 and was introduced to the House on March 18, 2025. Bill HR 2197's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 18, 2025

Bipartisan Support of Bill HR 2197

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 2197

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 2197

To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.

Start holding our government accountable!